ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

APLM Apollomics Inc

0.372
-0.0246 (-6.20%)
May 10 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Apollomics Inc APLM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0246 -6.20% 0.372 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.402 0.3611 0.418 0.3719 0.3966
more quote information »

Recent News

Date Time Source Heading
5/08/202415:05GLOBEApollomics Announces Private Placement Financing and..
4/25/202407:30GLOBEApollomics Announces Approval of Vebreltinib in China as a..
4/10/202406:00GLOBEApollomics Presents Vebreltinib Data at the 2024 American..
4/02/202407:00GLOBEApollomics Announces Poster Presentations of Vebreltinib..
3/28/202406:00GLOBEApollomics Highlights Clinical Progress and Reports Full..
3/26/202407:00GLOBEApollomics to Announce Full Year 2023 Financial Results and..
3/04/202406:00GLOBEApollomics Appoints Matthew Plunkett, Ph.D. as Chief..
2/07/202406:00GLOBEApollomics to Present at the Oppenheimer 34th Annual..
1/19/202415:15GLOBEApollomics Receives Nasdaq Notification Regarding Minimum..
1/17/202415:30GLOBEApollomics to Participate in a Fireside Chat at the B. Riley..
1/03/202406:00GLOBEApollomics Completes Enrollment in Phase 3 Bridging Study of..
1/02/202415:30GLOBEApollomics to Present at the 2024 Biotech Showcase
12/04/202306:00GLOBEApollomics Presents Interim Data from Two Ongoing Phase 2..
11/29/202306:30GLOBEApollomics to Participate in a Fireside Chat at the H.C...
11/28/202306:00GLOBEApollomics Announces Presentation of Vebreltinib Data at the..
11/16/202307:30GLOBEApollomics Announces the First Approval of Vebreltinib for..
10/31/202307:30GLOBEApollomics Announces Two New Cohorts in Global Phase 2..
10/26/202307:50GLOBEApollomics Announces Report of Activity of Vebreltinib in..
10/23/202307:30GLOBEApollomics Announces Efficacy of Vebreltinib in NSCLC..
10/16/202317:55GLOBEApollomics Announces Presentations of Vebreltinib Data at..
9/28/202315:17GLOBEApollomics Reports First Half 2023 Financial Results and..
9/06/202306:00GLOBEApollomics to Present at the H.C. Wainwright 25th Annual..